| Bioactivity | Steroid sulfatase/17β-HSD1-IN-5 is a irreversible inhibitor of steroid sulfatase (STS) .Steroid sulfatase/17β-HSD1-IN-5 is a reversible and selective inhibitor of 7β-hydroxysteroid dehydrogenase type1 (17β-HSD1), with IC50s of 43 nM and 6.2μM for 17β-HSD1 and 17β-HSD2, respectively. Steroid sulfatase/17β-HSD1-IN-5 can be used for metabolic disease (especially for endometriosis) research[1]. |
| Target | IC50: 43 nM (17β-HSD 1)IC50: 6.3 μM (17β-HSD 2)IC50: 0.4 μM (Steroid sulfatase) |
| Invitro | Steroid sulfatase/17β-HSD1-IN-5 (Compound 5) (0-40 μM;48-72 小时) 在浓度高达 31 μM (HEK293) 和 23 μM (HepG2)时,对细胞活力没有影响[1]。 Cell Viability Assay[1] Cell Line: |
| In Vivo | Steroid sulfatase/17β-HSD1-IN-5 (Compound 5) (皮下注射,50 mg/kg,单次给药) 显示 T1/2 为 3.82 小时,和 Cmax obs 为 2824 nM[1]。 Animal Model: |
| Name | Steroid sulfatase/17β-HSD1-IN-5 |
| Formula | C21H22N2O6S |
| Molar Mass | 430.47 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Mohamed Salah, et.al. Potent Dual Inhibitors of Steroid Sulfatase and 17β-Hydroxysteroid Dehydrogenase Type 1 with a Suitable Pharmacokinetic Profile for In Vivo Proof-of-Principle Studies in an Endometriosis Mouse Model.Journal of Medicinal Chemistry 2023 66 (13), 8975-8992. |